Simplify Logo

Full-Time

Therapeutic Sales Specialist

Cincinnati

Confirmed live in the last 24 hours

BridgeBio

BridgeBio

501-1,000 employees

Develops medicines for genetic diseases

Biotechnology
Healthcare

Compensation Overview

$140k - $185kAnnually

+ Performance Bonus + Equity + Health Benefits

Senior, Expert

Remote in USA

Category
Field Sales
Sales & Account Management
Required Skills
Sales
Communications
Data Analysis
Requirements
  • 8+ years of successful experience in the pharmaceutical industry and 5+ years in Rare Disease/Cardiology/Specialty/ATTR
  • BS/BA Required, MBA Preferred but not required
  • Product/indication launch experience: Track record of successfully launching new products and/or new indications into highly competitive markets
  • Strong leadership, planning and organization, analytics, business acumen, decision making and problem-solving skills
  • Ability to prioritize and execute on plan
  • Proven leadership skills with a history of holding oneself to a high level of accountability
  • Ability to influence without authority, internally as well as externally
  • Excellent written and oral communication skills
  • Excellent skills in using remote technology to engage with customers
  • Adherence to BridgeBio’s high ethical standards
  • Significant travel is required
Responsibilities
  • Meeting and/or exceeding sales goals in an assigned territory by developing, implementing, and executing an integrated territory business plan encompassing key customer target
  • Will demonstrate subject matter expertise concerning scientific and clinical information for Acoramidis
  • Will take a customer centric-approach and engage customers in clinically relevant discussion utilizing approved materials
  • Will effectively analyze sales data to identify opportunities for business growth or areas of concern in their territory
  • Be responsible for territory business planning and execution of key company initiatives
  • Will adhere to company guidelines and demonstrate honesty, integrity, trust, respect, and accountability and perform all responsibilities in accordance with company policies and procedures and applicable state and federal rules and regulations
  • Appropriately or compliantly? partners with Medical Science Liaisons, Field Reimbursement, Patient Access, HUB and other key cross-functional team members to develop strategies to ensure a high level of customer satisfaction
  • Navigates the hospital formulary process and develops and implements strategies to ensure successful product positioning and availability
  • Anticipates potential business challenges, adjusts priorities as needed, demonstrates flexibility, and develops solutions to address challenges
  • Maintains an exceptional level of proficiency in selling skills, clinical, market and product knowledge and the business environment of the territory
  • Collaborates with peers and company personnel to ensure corporate objectives and initiatives are achieved
  • Effectively plans and organizes schedule to ensure maximum efficiency and use of time to accomplish goals and objectives
  • Acts as an ambassador on behalf of the company. Presents a professional image and represents the company, products and people with integrity and respect
  • Completes tasks and projects assigned by Sales Leadership
  • Ensures that all activities are following applicable regulations, compliance and Pharma guidelines

BridgeBio Pharma develops medicines specifically for genetic diseases, focusing on conditions with well-understood genetic causes. The company operates using a decentralized subsidiary model, where each subsidiary concentrates on creating therapies for particular diseases while sharing central resources. This structure enhances efficiency and allows for the simultaneous advancement of multiple drug programs. BridgeBio utilizes advancements in genome sequencing and molecular biology to identify and develop effective treatments. Unlike many competitors, BridgeBio emphasizes independent thinking and transparency, enabling rapid, data-driven decision-making. The company's goal is to create significant therapeutic advancements by targeting diseases at their genetic source, ultimately bringing effective treatments to market more quickly.

Company Stage

IPO

Total Funding

$6.8B

Headquarters

Palo Alto, California

Founded

2014

Growth & Insights
Headcount

6 month growth

12%

1 year growth

53%

2 year growth

56%
Simplify Jobs

Simplify's Take

What believers are saying

  • Significant investments, such as the $46.84 million from Norges Bank and $200 million for the oncology spinout, indicate strong financial backing and growth potential.
  • The launch of BridgeBio Oncology Therapeutics with $200 million in funding highlights the company's commitment to advancing cancer treatments, particularly KRAS inhibitors.
  • Equity grants to new employees under the Amended and Restated 2019 Inducement Equity Plan demonstrate BridgeBio's commitment to attracting and retaining top talent.

What critics are saying

  • The competitive landscape in genetic disease therapies and oncology is intense, with numerous companies vying for market share.
  • The decentralized subsidiary model, while efficient, may lead to challenges in maintaining cohesive strategic direction and operational alignment.

What makes BridgeBio unique

  • BridgeBio's decentralized subsidiary model allows for focused and efficient drug development across multiple genetic diseases simultaneously, unlike traditional centralized biopharma companies.
  • The company's emphasis on genetic diseases with well-understood causes enables targeted and potentially more effective therapies, setting it apart from competitors with broader, less focused pipelines.
  • BridgeBio's robust pipeline of over 15 drug programs targeting 20 different genetic diseases showcases its diversified approach, reducing the traditional biopharma process timeline.